Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000676413 | SCV001724796 | benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676413 | SCV005236716 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117701 | SCV000151948 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Mayo Clinic Laboratories, |
RCV000676413 | SCV000802190 | likely benign | not provided | 2016-03-07 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003964985 | SCV004778861 | benign | NDUFA9-related disorder | 2019-07-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |